These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18097246)

  • 1. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography.
    Park IN; Ryu JS; Shim TS
    Clin Nucl Med; 2008 Jan; 33(1):1-3. PubMed ID: 18097246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis.
    Tian G; Xiao Y; Chen B; Xia J; Guan H; Deng Q
    Acta Radiol; 2010 Nov; 51(9):1002-6. PubMed ID: 20942732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases.
    Goo JM; Im JG; Do KH; Yeo JS; Seo JB; Kim HY; Chung JK
    Radiology; 2000 Jul; 216(1):117-21. PubMed ID: 10887236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
    Martinez V; Castilla-Lievre MA; Guillet-Caruba C; Grenier G; Fior R; Desarnaud S; Doucet-Populaire F; Boué F
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1180-5. PubMed ID: 22794271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET in a myocardial tuberculoma.
    Braquet P; Baptista G; Ilonca DA; Roubille F; Le Moing V; Jeandel C
    Age Ageing; 2015 Jan; 44(1):173-4. PubMed ID: 25331974
    [No Abstract]   [Full Text] [Related]  

  • 6. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
    Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential
    Bomanji J; Sharma R; Mittal BR; Gambhir S; Qureshy A; Begum SMF; Paez D; Sathekge M; Vorster M; Sobic Saranovic D; Pusuwan P; Mann V; Vinjamuri S; Zumla A; Pascual TNB
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3118-3129. PubMed ID: 32483653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The findings of fluorodeoxyglucose F18 imaging of coincidence single photon emission computed tomography in the lung tuberculoma].
    Lü PX; Zhou XH; Luo BJ; Zhou Z; Zhao ZG; Wang QF
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Aug; 33(8):597-600. PubMed ID: 20979848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare image of a pulmonary nodule revealed on FDG-PET scans.
    Ichikawa M; Iwakami S; Fujii M; Takahashi K
    Intern Med; 2010; 49(20):2275-6. PubMed ID: 20962451
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis.
    Demura Y; Tsuchida T; Uesaka D; Umeda Y; Morikawa M; Ameshima S; Ishizaki T; Fujibayashi Y; Okazawa H
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):632-9. PubMed ID: 19093113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality FDG PET/CT appearance of pulmonary tuberculoma mimicking lung cancer and pathologic correlation in a tuberculosis-endemic country.
    Zheng Z; Pan Y; Guo F; Wei H; Wu S; Pan T; Li J
    South Med J; 2011 Jun; 104(6):440-5. PubMed ID: 21886034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity.
    Kim IJ; Lee JS; Kim SJ; Kim YK; Jeong YJ; Jun S; Nam HY; Kim JS
    Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):808-14. PubMed ID: 18097664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
    Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
    Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
    Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
    J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
    Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH
    Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
    Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
    J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
    Konski AA; Cheng JD; Goldberg M; Li T; Maurer A; Yu JQ; Haluszka O; Scott W; Meropol NJ; Cohen SJ; Freedman G; Weiner LM
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):358-63. PubMed ID: 17532577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.